the aid library

LIST OPTIONS

Filter

448

Download (240)

View PDF (343)

HIV and AIDS in South Africa

Avert (2018) C2

External Link

Same‐day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study

Langwenya, Nontokozo; Phillips, Tamsin K.; Brittain, Kirsty et al. (2018) CC

Journal of the International AIDS Society Vol. 21 (2018) e25133
Many prevention of mother-to-child HIV transmission programmes across Africa initiate HIV-infected (HIV positive) pregnant women on lifelong antiretroviral therapy (ART) on the first day of antenatal care (“same-day” initiation... more

Download (215)

View PDF (413)

Update of recommendations on first- and second-line antiretroviral regimens - Policy Brief

World Health Organization (2019) C_WHO

HIV Treatment

External Link

TB and the NSP - Are we on track?

Spotlight NSP (2013) C2

NSP Review Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013 A publication of the Treatment Action Campaign and SECTION27 GeneXpert: An imperfect rollout TB in South African prisons: Where to now? Decentralising DR-TB care: How far alon... more

Download (250)

View PDF (350)

Recommended package of interventions for HIV, viral hepatis and STI prevention, diagnosis, treatment and care for people who inject drugs: policy brief

World Health Organisation (WHO) (2023) C_WHO

HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination... more

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Download (421)

View PDF (1013)

Health worker migration from South Africa: causes, consequences and policy responses

Labonté et al Human Resources for Health (2015) CC

Download (271)

View PDF (348)

Руководство по самотестированию на ВИЧ и информированию партнеров - Дополнение к сводному руководству по услугам тестирования на ВИЧ

Всемирная организация здравоохранения Всемирная организация здравоохранения (Европа); European Centre for Disease Prevention and Control (ECDC) (2018) C_WHO

ДОПОЛНЕНИЕ СЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ ДЕКАБРЬ 2016 г.

External Link

Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses

S. Rueda; S. Mitra; S. Chen; et al. BMJ Open; Pub Med (2016) CC

Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453

Download (183)

View PDF (228)

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 9

World Health Organization (WHO) World Health Organization (WHO) (2017) C_WHO

Module 9 Strategic planning July 2017 Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh... more

Download (194)

View PDF (302)

САМОТЕСТИРОВАНИЮ НА ВИЧ И ИНФОРМИРОВАНИЮ ПАРТНЕРОВ

Всемирная организация здравоохранения (ВОЗ) Всемирная организация здравоохранения (ВОЗ) (2018) C_WHO

РУКОВОДСТВО ПО ДОПОЛНЕНИЕ К СВОДНОМУ РУКОВОДСТВУ ПО УСЛУГАМ ТЕСТИРОВАНИЯ НА ВИЧ ДЕКАБРЬ 2016 г. УСЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ

Download (232)

View PDF (250)

Herramienta de la OMS para la implementación de la profilaxis previa a la exposición al VIH - Módulo 9

Organización Mundial de la Salud (Américas); Organización Panamericana de la Salud Organización Mundial de la Salud (Américas); Organización Panamericana de la Salud (2019) C_WHO

Módulo 9 Planificación estratégica Julio del 2017 Módulo 9: Planificación estratégica. La OMS recomienda ofrecer la PrEP a las personas con un riesgo significativo de contraer la infección por el VIH, por lo que este módulo ofrece orientación de salud pública para los encargados de ... more

Download (231)

View PDF (247)

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 5

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO

Module 5 Monitoring and Evaluation October 2018 Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona... more

Download (584)

View PDF (1408)

Étude sur les outils juridiques à la disposition des ordres de pharmaciens dans la lutte contre les médicaments falsifiés (Bénin, Burkina Faso, Guinée, Mali)

Locher, F. PUPH, Université Lyon1 (ISPB-Faculté de Pharmacie) et Hospices Civils de Lyon (2015) C5

Dans le cadre du projet Tracmed, une étude sur les outils législatifs et juridiques à disposition des ordres des pharmaciens dans la lutte contre les médicaments falsifiés a été réalisée en juillet 2015. Cette étude porte sur le Bénin, le Burkina Faso, la Guinée et le Mali.